Galectin Therapeutics Inc —— 资产负债表 (NASDAQ:GALT) | MetaTrader

展开完整图表

Financials

概览声明统计

每季度年度

总资产 29.6 M41.83 M21.29 M28.2 M17.5 M19.53 M 负债总额 5.41 M39.21 M53.48 M88.44 M120.56 M145.73 M 权益总额 22.47 M893 K-33.92 M-61.96 M-104.79 M-127.92 M 负债及股东权益总额 29.6 M41.83 M21.29 M28.2 M17.5 M19.53 M 总债务 —8 000———— 净债务 —-39.64 M————

新闻

Galectin Therapeutics任命约翰斯·霍普金斯神经外科医生进入董事会

Galectin Therapeutics appoints Johns Hopkins neurosurgeon to board

Galectin Therapeutics Inc. (GALT) Discusses Updated Results for Belapectin in Treatment of MASH Cirrhosis and Portal Hypertension Transcript

Galectin Therapeutics董事Marc Rubin辞去董事会职务

Galectin Therapeutics director Marc Rubin resigns from board

嘉莱科特治疗公司CFO出售价值23.3万美元股票

Galectin Therapeutics CFO sells $233k in shares

Galectin Therapeutics: Runway With Convertible Financing But Dilution Overhang Remains

oracle, micron tech among market cap stock movers on friday

Galectin Therapeutics股价在FDA反馈药物进展后暴跌

Galectin Therapeutics stock plummets after FDA feedback on drug

FDA provides feedback on Galectin’s belapectin development program